Skip Navigation

European Heart Journal 2002 23(1):70-78; doi:10.1053/euhj.2001.2780
Copyright © 2002 by the European Society of Cardiology.
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow References
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (22)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Kell, R.
Right arrow Articles by Haass, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kell, R.
Right arrow Articles by Haass, M.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Do cytokines enable risk stratification to be improved in NYHA functional class III patients?. Comparison with other potential predictors of prognosis

R. Kell, A. Haunstetter, T.J. Dengler, C. Zugck, W. Kübler and M. Haassf1

Department of Cardiology, University of Heidelberg, Heidelberg, Germany

Received February 13, 2001; accepted April 25, 2001

Abstract

Aims Elevated plasma levels of proinflammatory cytokines have been reported in patients with congestive heart failure. The purpose of this study was to assess whether cytokines improve risk stratification in a homogenous group of NYHA class III patients with a left ventricular ejection fraction <40%.

Methods and Results Plasma concentrations of big endothelin, tumour necrosis factor alpha, interleukins -1, -6, -10 and -12, sCD14 and GM-CSF were measured by ELISA in 91 NYHA III patients [mean (SD) age: 55 (10) years, 69% male, 34% coronary artery disease, 66% dilated cardiomyopathy] with a left ventricular ejection fraction and a peak oxygen uptake (peak VO2) of 19 (9)% and 12·1 (3·6)ml min–1.kg–1, respectively. During follow-up [22 (13) months], 31 patients (34%) died due to cardiovascular causes. In non-survivors, interleukin-6 was twice as high as in survivors [12·8 (16·9)pg.ml–1vs 5·6(5·3)pg.ml–1,P <0·003], whereas plasma concentrations of the other cytokines showed no significant differences. Concerning long-term survival (≥1 year), multivariate Cox regression analysis revealed an independent prognostic power for interleukin-6, which was further improved by combining with left ventricular ejection fraction and peak VO2, while for short-term survival (up to 6 months) interleukin-6 did not allow risk stratification.

Conclusion In NYHA class III patients, plasma concentrations of interleukin-6 are predictive of long-term survival. However, its value may be limited for clinical decision-making for cardiac transplantation (short-term survival).

Key Words: Cytokines, heart failure, interleukin-6, risk stratification

f1 Correspondence: Markus Haass, MD, Department of Cardiology, University of Heidelberg, Bergheimer Str. 58, D-69115 Heidelberg, Germany.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Eur J Heart FailHome page
J. Junger, D. Schellberg, T. Muller-Tasch, G. Raupp, C. Zugck, A. Haunstetter, S. Zipfel, W. Herzog, and M. Haass
Depression increasingly predicts mortality in the course of congestive heart failure
Eur J Heart Fail, March 2, 2005; 7(2): 261 - 267.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
R. Marfella, K. Esposito, M. Siniscalchi, F. Cacciapuoti, F. Giugliano, D. Labriola, M. Ciotola, C. Di Palo, L. Misso, and D. Giugliano
Effect of Weight Loss on Cardiac Synchronization and Proinflammatory Cytokines in Premenopausal Obese Women
Diabetes Care, January 1, 2004; 27(1): 47 - 52.
[Abstract] [Full Text] [PDF]


Home page
Eur J Heart FailHome page
R. Gaertner, D. Lepailleur-Enouf, W. Gonzalez, A. Nicoletti, C. Mandet, M. Philippe, J.-J. Mercadier, and J.-B. Michel
Pulmonary endothelium as a site of synthesis and storage of interleukin-6 in experimental congestive heart failure
Eur J Heart Fail, August 1, 2003; 5(4): 435 - 442.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
A. D'Aloia, P. Faggiano, G. Aurigemma, L. Bontempi, G. Ruggeri, M. Metra, S. Nodari, and L. Dei Cas
Serum levels of carbohydrate antigen 125 in patients with chronic heart failure: Relation to clinical severity, hemodynamic and Doppler echocardiographic abnormalities, and short-term prognosis
J. Am. Coll. Cardiol., May 21, 2003; 41(10): 1805 - 1811.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
R. S. Vasan, L. M. Sullivan, R. Roubenoff, C. A. Dinarello, T. Harris, E. J. Benjamin, D. B. Sawyer, D. Levy, P. W.F. Wilson, and R. B. D'Agostino
Inflammatory Markers and Risk of Heart Failure in Elderly Subjects Without Prior Myocardial Infarction: The Framingham Heart Study
Circulation, March 25, 2003; 107(11): 1486 - 1491.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
R. Ferrari
Interleukin-6: a neurohumoral predictor of prognosis in patients with heart failure: light and shadow
Eur. Heart J., January 1, 2002; 23(1): 9 - 10.
[Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.